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The fungus Fusarium verticillioides (Sacc.)
Nirenberg (synonym: F. moniliforme Sheldon;
teleomorph Gibberella moniliformis Wineland)
is one of the most prevalent seed-borne fungi
associated with corn (maize, Zea mays L.)
intended for human and animal consumption
throughout the world (1). The fumonisins, a
family of foodborne carcinogenic mycotoxins,
were ﬁrst isolated in 1988 from cultures of F.
verticillioides strain MRC 826 at the
Programme on Mycotoxins and Experimental
Carcinogenesis (PROMEC) of the Medical
Research Council (MRC) in Tygerberg,
South Africa, by Gelderblom et al. (2). Also in
1988, the structures of the fumonisins were
also elucidated in a collaborative effort
between the PROMEC and the Council for
Scientific and Industrial Research (CSIR) in
Pretoria (3). Fumonisin B1 (FB1), in a collab-
orative effort between PROMEC and the
Onderstepoort Veterinary Research Institute
in South Africa (4), was shown to cause
equine leukoencephalomalacia (ELEM).
The isolation and chemical characteriza-
tion of the fumonisins in South Africa in
1988 was the culmination of 18 years
(1970–1988) of intensive dedicated research
by a multidisciplinary team with members at
each of the above-mentioned three institu-
tions. In this historical perspective, we
describe the events during this period that led
to the isolation of the fumonisins in 1988,
and highlight the ﬁrst 10 years (1988–1998)
of fumonisin research. 
Events Leading to the
Characterization of the
Fumonisins in South Africa:
1970–1988
F. verticillioides was the predominant fungus
isolated from moldy corn associated with a
ﬁeld outbreak of ELEM in South Africa dur-
ing 1970 characterized by liquefactive
necrotic lesions in the white matter of the
cerebral hemispheres of horses (1,5). The
causative role of F. verticillioides in ELEM (6)
was subsequently confirmed with several
South African isolates of the fungus, and the
pathognomonic pathologic changes were
described in detail (5,7). The occurrences of
bile duct proliferation, increased numbers of
mitotic figures, multinucleated hepatocytes,
and large, bizarre hyperchromatic nuclei in
the livers of these horses (5,7) were the first
indications that F. verticillioides might be a
carcinogenic fungus.
Subsequently, we became involved in a
study of the possible role of fungal toxins in
the etiology of human esophageal cancer
(EC) in the Transkei region of South Africa.
The incidence rate of EC in males and
females in the southern part of Transkei is
among the highest in the world, whereas the
rate in the northern part of Transkei is low
(8,9). The staple diet in both areas is home-
grown corn, and F. verticillioides was shown
to be the most prevalent fungus in corn
consumed by people in areas with a high
incidence of EC (10).
In continuing investigations on the toxi-
cology of F. verticillioides isolates from corn
associated with field outbreaks of ELEM in
horses, isolates from corn in areas in Transkei
with a high risk of EC were included. One of
these Transkeian isolates, designated F. verti-
cillioides MRC 826, was soon found to cause
ELEM experimentally in horses and porcine
pulmonary edema (PPE) in pigs (11) and to
be highly hepatotoxic and cardiotoxic in rats
(11,12). In 1984, culture material of F. verti-
cillioides MRC 826 was shown to be hepato-
carcinogenic in rats and to cause primary
hepatocellular carcinoma and cholangio-
carcinoma (13). 
Although chemical investigations on the
mycotoxin(s) produced by F. verticillioides
MRC 826 began in South Africa in July
1970, the chemical nature of the metabolite(s)
responsible for ELEM still had not been iden-
tiﬁed in 1984 when the fungus was shown to
be carcinogenic. The isolation and chemical
characterization of the mycotoxin(s) and car-
cinogen(s) produced by F. verticillioides then
became a matter of paramount importance.
The urgency of the matter was accentuated
further when researchers in the United States
reported that corn implicated in field out-
breaks of ELEM and naturally infected by F.
verticillioides was also hepatocarcinogenic in
rats (14). The pathologic changes in these rats
were identical to those that had been described
in 1984 in rats fed culture material of F. verti-
cillioides MRC 826 by Marasas et al. (13). This
provided evidence that the unidentified car-
cinogen(s) produced by F. verticillioides
This article describes the events leading to the discovery of the fumonisins in South Africa in 1988
and highlights the ﬁrst 10 years (1988–1998) of fumonisin research. The predominant fungus isolated
from moldy corn implicated in a ﬁeld outbreak of equine leukoencephalomalacia (ELEM) in South
Africa in 1970 was Fusarium verticillioides (F. moniliforme). This fungus was also prevalent in moldy
home-grown corn consumed by people in high-incidence areas of esophageal cancer (EC) in the
Transkei region of South Africa. Culture material on corn of F. verticillioides strain MRC 826, which
was isolated from moldy corn in Transkei, was shown to cause ELEM in horses, porcine pulmonary
edema (PPE) syndrome in pigs, and liver cancer in rats. A short-term cancer initiation/promotion
assay in rat liver was used to purify the carcinogen(s) in the culture material. These efforts ﬁnally met
with success when fumonisins B1 and B2, novel mycotoxins with cancer-promoting activity in rat
liver, were isolated from culture material of F. verticillioides MRC 826 at the Programme on
Mycotoxins and Experimental Carcinogenesis of the Medical Research Council in Tygerberg, South
Africa. Following the elucidation of the chemical structure of the fumonisins, these carcinogenic
mycotoxins were shown to occur naturally in moldy corn in Transkei. Shortly thereafter, high levels of
fumonisins in the 1989 U.S. corn crop resulted in large-scale ﬁeld outbreaks of ELEM and PPE in
horses and pigs, respectively, in the United States. Subsequently the fumonisins were found to
occur naturally in corn worldwide, including corn consumed as the staple diet by people at high risk
for EC in Transkei and China. These ﬁndings, together with the fact that the fumonisins cause ﬁeld
outbreaks of mycotoxicoses in animals, are carcinogenic in rats, and disrupt sphingolipid metabolism,
have resulted in much worldwide interest in these compounds during the ﬁrst 10 years after the
discovery of the fumonisins in 1988. Key words: corn, esophageal cancer, fumonisins, Fusarium
moniliforme, Fusarium verticillioides, leukoencephalomalacia, porcine pulmonary edema syndrome,
South Africa. — Environ Health Perspect 109(suppl 2):239–243 (2001).
http://ehpnet1.niehs.nih.gov/docs/2001/suppl-2/239-243marasas/abstract.html
This article is based on a presentation at the International
Conference on the Toxicology of Fumonisin held 28–30
June 1999 in Arlington, Virginia, USA.
Address correspondence to W.F.O. Marasas,
PROMEC, MRC, PO Box 19070, Tygerberg 7505,
South Africa. Telephone: 27 21 938 0290. Fax: 27 21
938 0260. E-mail: wally.marasas@mrc.ac.za
I am indebted to all my colleagues at PROMEC and
our collaborators for their contributions to the discov-
ery of and the ﬁrst 10 years of research on the fumon-
isins. The continued financial support of the South
African Medical Research Council is gratefully acknowl-
edged.
Received 10 April 2000; accepted 13 July 2000.
Discovery and Occurrence of the Fumonisins: A Historical Perspective
Walter F.O. Marasas
Programme on Mycotoxins and Experimental Carcinogenesis, Medical Research Council, Tygerberg, South Africa
109S2.Part 2  04/16/01  4:36 PM  Page 239    (Black plate)Marasas
240 VOLUME 109 | SUPPLEMENT 2 | May 2001 • Environmental Health Perspectives
was present not only in culture material of
F. verticillioides MRC 826 but also occurred
naturally in corn in the United States. 
In 1984 the following mycotoxins were
known to be produced by F. moniliforme,
according to the literature: deoxynivalenol;
diacetoxyscirpenol, fusaric acid; fusarins A,
B, C, and D; fusariocins; gibberellins; monil-
iformin; T-2 toxin; and zearalenone (1). We
knew, however, that F. verticillioides MRC
826 did not produce moniliformin, tri-
chothecenes, or zearalenone (1,12,15). We
also knew that a chloroform/isopropanol
extract of culture material of F. verticillioides
MRC 826 was highly mutagenic to
Salmonella typhimurium in the Ames test
(16,17). Consequently, intensive efforts were
made to isolate and characterize the muta-
gen(s) because most mutagens are also car-
cinogens. A group of structurally related
compounds, the fusarins, were isolated. One
of these, fusarin C, was very promising, as it
was highly mutagenic in the Ames test and
occurred naturally in Transkeian corn
(17,18) as well as in corn from the United
States that had been shown to be hepatocar-
cinogenic in rats (19). Consequently, short-
term carcinogenicity assays with fusarin C
and long-term trials in rats with culture
material of F. verticillioides MRC 1069 that
contained high levels of fusarin C were per-
formed (20,21). However, no evidence could
be found of the carcinogenicity of fusarin C.
It was concluded that fusarin C was not the
carcinogenic metabolite present in culture
material of F. verticillioides MRC 826. In
view of the findings that fusarin C was not
carcinogenic and because it is heat and light
sensitive, it was concluded that fusarin C is
not a threat to human health.
Thus, the search continued for the elu-
sive F. verticillioides carcinogen. During our
investigations on the carcinogenicity of
fusarin C, a short-term initiation/promotion
assay in rat liver was developed. This
involved partial hepatectomy of rats,
followed by administration of an initiator
such as diethylnitrosamine (DEN), followed
by administration of a promotor such as phe-
nobarbital. After 14 weeks, the gamma glu-
tamyltranspeptidase (GGT) activity was
determined histochemically in the liver
(2,20,22). During the application of this
short-term carcinogenicity assay, it was
found that culture material of F. verticil-
lioides MRC 826 initiated the formation of
early lesions in the liver and exhibited
cancer-promoting activity. The short-term
cancer initiation/promotion assay, with
DEN as initiator and the ability of fractions
of extracts of the culture material to selec-
tively stimulate the development of GGT-
altered foci in rat liver, was used as a bioassay
in the isolation of the active principle(s) (2).
All these efforts ﬁnally succeeded in 1988,
when the chemical nature of the carcinogen
was unraveled. FB1 and fumonisin B2 (FB2),
novel mycotoxins with cancer-promoting
activity in rat liver, were isolated from cultures
of F. verticillioides MRC 826 at PROMEC
(2). The structures of FB1 and FB2 were eluci-
dated in collaboration with the CSIR (3).
The elucidation of the chemical structure
of the fumonisins, together with the demon-
stration in 1988 of the biologic activity of
FB1, was the end of an era and the beginning
of a new one. From 1970–1988, the toxicity
of culture material of F. verticillioides MRC
826 to horses and pigs and the carcinogenic-
ity to rats were established. From 1988–1991,
the stage was set for a new era of research on
the biologic activity of chemically character-
ized fumonisins rather than crude fungal
cultures and/or extracts.
Fumonisins: The First 
10 Years: 1988–1998
Biologic Activity and Natural
Occurrence: 1988–1991
Pure FB1 was first shown in 1988 to cause
ELEM in horses by intravenous injection (4)
and by oral dosing in 1990 (23). Pure FB1
was shown in 1990 to cause PPE in pigs by
intravenous injection (24) and to cause liver
cancer in male BD IX rats at a dietary level of
50 µg/g (25).
The natural occurrence of FB1 in home-
grown corn from Transkei was ﬁrst reported
in January 1990 by Sydenham et al. (26).
The first quantitative and sensitive high-
performance liquid chromatography method
for the simultaneous determination of FB1
and FB2 in naturally contaminated corn and
mixed feed was published in June 1990 by
Shephard et al. (27). Using this analytical
method, Sydenham et al. (28) showed that
home-grown corn from areas in Transkei
with a high incidence of EC contained signif-
icantly higher levels of both FB1 and FB2
than corresponding samples from low-inci-
dence areas. In 1981 a correlation was shown
between the incidence of the fungus F. verti-
cillioides in home-grown corn and the inci-
dence of EC in Transkei (10), whereas in
1990 a correlation was shown between the
levels of FB1 and FB2 in home-grown corn
and the incidence of EC in Transkei (28).
It is remarkable that the fumonisins were
launched into international importance
shortly after their discovery in South Africa in
1988 by events that occurred in the United
States during 1989 and 1990. These events
occurred shortly after publication of the
structure of the fumonisins in 1988 (2) but
just before the publication of a sensitive
chemical analytical method for FB1 and FB2
in June 1990 (27).
The Great American Outbreaks: 
1989–1990
During the fall of 1989 and the winter of
1990, widespread, large-scale outbreaks of
ELEM and PPE occurred in the United
States. Large numbers of horses and pigs died
from consuming commercial mixed feeds
containing fumonisin-contaminated corn
from the 1989 U.S. corn crop (24,29–33).
Great Activity and International Agency
for Research on Cancer Evaluation:
1990–1993
The disastrous consequences of the contami-
nation of the 1989 U.S. corn crop with high
levels of fumonisins triggered a great deal of
interest in and research on the fumonisins in
the United States and elsewhere (34–40).
This resulted in a sharp increase in the num-
ber of publications dealing with the fumon-
isins (41), including several comprehensive
Table 1. Incidence of Fusarium verticillioides in home-
grown corn from Transkei.a
Mean % kernels infected
Low incidence High incidence 
Season of EC  of EC  p <
Healthy corn
1976 5.0 41.5 0.0001
1979 5.0 23.1 0.01
1985 8.3 42.0 0.001
1986 9.0 43.0 0.01
1989 8.9 41.2 0.01
Moldy corn
1977 17.0 25.7 0.005
1979 9.8 33.4 NS
1985 34.5 67.7 0.01
1989 21.4 61.7 0.01
NS, not signiﬁcant.
aData from Rheeder et al. (53).
Table 2. Levels of fumonisins in home-grown corn from
Transkei.a
Mean fumonisin levels (µg/g)b
Low incidence High incidence 
Season of EC of EC p <
Healthy corn
1985 0.3 2.1 0.001
1989 0.6 2.0 NS
Moldy corn
1985 9.0 31.5 0.01
1989 5.1 67.4 0.005
aData from Rheeder et al. (53). bTotal fumonisins in positive
samples.
Table 3. Incidence of F. graminearum and levels of
DON, NIV, and ZEA in moldy corn from Transkei in
1985.a
Low incidence High incidence 
of EC of EC p <
F. graminearum (%) 34.9 8.0 0.01
DON (µg/g) 2.9 0.3 NS
NIV (µg/g) 4.6 1.8 0.05
ZEA (µg/g) 1.2 0.4 0.01
aData from Sydenham et al. (28) and Rheeder et al. (53).
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reviews (41–48). The First Conference on
Fumonisins was held in Ames, Iowa, USA,
from 6 to 7 September 1990. This was fol-
lowed by other international conferences on
fumonisins (49,50).
The International Agency for Research on
Cancer in Lyon, France, evaluated the toxins
produced by F. moniliforme as Group 2B car-
cinogens (i.e., possibly carcinogenic to humans)
in 1993 (51). 
Esophageal Cancer in Transkei
Revisited: 1981–1998
At this juncture we return to Transkei in
South Africa, where we first demonstrated a
link between F. verticillioides and EC in 1981
(10) and between fumonisins and EC in
1990 (28). These correlations between the
incidence of F. verticillioides and fumonisin
levels in home-grown corn and EC rate were
conﬁrmed in 1988 (52) and 1992 (53). The
data obtained in Transkei over six seasons
between 1976 and 1989 are summarized in
Tables 1 and 2.
It is clear from Table 1 that F. verticil-
lioides is significantly more prevalent in
healthy corn as well as moldy corn from areas
with a high incidence of EC than from those
areas with a low incidence of EC in Transkei.
Similarly, fumonisin levels in healthy as well
as moldy corn from areas with a high inci-
dence of EC are significantly higher than in
areas with low incidence (Table 2). The data
clearly identify the area with a high incidence
of EC, comprising Kentani and Butterworth
districts in southern Transkei, as an ecologic
zone that favors the infection of corn ears by
F. verticillioides and the concomitant produc-
tion of fumonisins in the infected kernels.
Conversely, the areas with low incidence,
comprising Bizana and Lusikisiki districts in
northern Transkei, are not favorable for the
development of F. verticillioides ear rot and
fumonisin production in corn. In fact, the
area with a low incidence of EC was found to
be much more conducive to another
Fusarium sp. that causes ear rot of corn, i.e.,
F. graminearum Schwabe, and the production
of three mycotoxins by this fungus, i.e.,
deoxynivalenol (DON), nivalenol (NIV), and
zearalenone (ZEA), in corn than the area with
a high incidence of EC (Table 3). The two
areas are compared in Table 4 with respect to
climatic, geographic, geologic, and soil fertil-
ity factors that may be important in deter-
mining the mycotoxicologic differences
between the areas.
Incidence rates of EC in high-incidence
(Kentani district) and low-incidence (Bizana
district) areas in Transkei from 1955 to 1990
are compared in Table 5. It is clear that from
1955 to 1959 the two areas were distinctly
different with respect to EC incidence rates in
both males and females, i.e., very low (2.6
and 1.8) in Bizana and very high (54.2 and
30.3) in Kentani. The rates in Kentani have
consistently stayed very high and in
1985–1990 were very similar (55.6 and 22.1)
to those recorded from 1955 to 1959. In
Bizana, however, incidence rates in both
males and females increased markedly, and
from 1985 to 1990 the rates were not much
different (37.0 and 11.7) from those in
Kentani. Because of the numerous problems
and pitfalls associated with cancer registry in
remote rural areas of Africa, it is not clear
whether the increased EC rates in Bizana are
real or are reflections of changes in cancer
registry patterns due to demographic, socio-
economic, political, and/or other factors.
In a comparative study of the incidence of
esophageal cytologic abnormalities deter-
mined by means of brush biopsies in residents
of the two areas in 1985, it was found that
mild and advanced cytologic changes
occurred much more frequently in the high
EC area (Kentani, 50.0 and 36.7%, respec-
tively) than in the area with a low incidence
of EC (Bizana, 12.5 and 4.2%, respectively)
(52). It can be assumed that residents of both
areas in Transkei have nutritional deﬁciencies
for several mineral elements and vitamins, as
indicated by the blood biochemical parame-
ters in Table 6. Esophageal cytologic changes
were determined in the occupants of 12
households in each area, and samples of
healthy and moldy corn were collected simul-
taneously from each household and analyzed
for F. verticillioides and fumonisins (Table 7).
The incidence of advanced esophageal
cytologic changes was higher in the occupants
of the 12 households in the area with a high
incidence of EC than in the area with a low
incidence of EC, as were the levels of F. verti-
cillioides and of fumonisins in the corn from
the households in the area with a high inci-
dence of EC (Table 7). Although the occu-
pants of the households in both areas
probably suffered from underlying nutritional
deficiencies (Table 6), the residents of
Kentani district in the area with a high inci-
dence of EC had higher levels of fumonisins
in the home-grown corn stored in their
houses and also had higher incidences of
esophageal cytologic abnormalities than resi-
dents of Bizana district in the area with a low
incidence of EC (Table 7).
Although FB1 and FB2 were ﬁrst reported
to occur naturally in corn from Transkei
(26), fumonisins have also been reported sub-
sequently to occur in home-grown and/or
commercial corn in several other areas
throughout the world with a high incidence
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Table 4. Ecologic characteristics of areas with low and high incidence of EC in Transkei.a
Characteristic  Low incidence of EC, Bizana District High incidence of EC, Kentani District
Altitude 600–900 meters 200–400 meters
Average rainfall  800–950 millimeters 900–1000 millimeters
Geology Ecca, Dwyka Beaufort
Volcanically derived dolerite Sedimentary sandstones
General soil features Red, yellow/brown apedal with orthic  Weakly developed soils
epipedon (Hutton, Clovelly, Grifﬁn) Rock (Glenrosa, Mispah, Swartland)
Vegetation Coastal forest and Thornveld Thornveld - Bushveld
Soil fertility factors Soil organic matter and levels  Soil pH and levels of Mn, Ni, Mg, Ca, 
of Al and Fe signiﬁcantly higher and K signiﬁcantly higher
aData from Rheeder et al. (54).
Table 5. EC incidence rates in Transkei.a
ASIR
Low incidence High incidence
of EC,  of EC, 
Bizana District Kentani District
Period Males Females Males Females
1955–1959 2.6 1.8 54.2 30.3
1965–1969 10.5 4.4 39.7 16.1
1981–1984 19.5 15.0 45.0 23.3
1985–1990 37.0 11.7 55.6 22.1
ASIR, age standardized incidence rate/100,000/annum. 
aData from Makaula et al. (9).
Table 6. Some blood biochemical parameters of popula-
tions at risk for EC in Transkei.a
Blood biochemical
parameters Normal values Transkei
Selenium (ng/mL) 112–210 58–69
Vitamin A (µg/dL) 20–70 25–40
Vitamin B12 (pg/mL) 220–750 227–366
Vitamin E (µg/dL) > 6.0 3.7–5.3
Folic acid (ng/mL) 210–980 242–307
aData from Jaskiewicz et al. (55,56).
Table 7. Incidence of esophageal cytologic abnormali-
ties, F. verticillioides, and fumonisins in home-grown
corn in areas with low and high incidences of EC in
Transkei.a
Low incidence High incidence
of EC, of EC,
Bizana District Kentani District
Advanced cytologic 4.2 36.7
changes (%)b
Healthy Moldy Healthy  Moldy 
corn corn corn corn
F. verticillioides (%)c 8.3 34.5 42.0 67.7
Fumonisins (µg/g)c 0.3 9.0 2.1 31.5
aData from Marasas et al. (52) and Rheeder et al. (53). bIn occu-
pants of 12 households in each area in 1985. cIn samples of
healthy and moldy corn from each household.
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of EC (Table 8). It is clear that fumonisins
occur in corn consumed by humans at risk
for EC in some areas in Africa, Asia, Europe,
and the United States. The question remains
whether some individuals (who take in higher
levels of fumonisins in corn consumed as the
staple diet than others) are at higher risk to
develop cytologic abnormalities in the esoph-
agus that may terminate in EC. The ﬁrst step
required to answer this question is to assess
human fumonisin intake. For this assessment,
two approaches are used: calculation of the
probable daily intake (PDI) and measurement
of biomarkers for fumonisin exposure in
humans (61).
Human fumonisin intake can be calcu-
lated from analyses of naturally occurring lev-
els of fumonisins in corn and data on corn
intake and expressed as the PDI (Table 9).
Both the level of fumonisins in the corn and
the amount of corn consumed influence the
PDI (i.e., the higher the level and the larger
the amount consumed, the higher the PDI).
Large variations are apparent in the PDI,
ranging from 1.2 µg/kg body weight
(bw)/day, in urban South Africans consuming
commercial corn, to 354.9 µg/kg bw/day, in
rural South Africans consuming moldy
home-grown corn. The rural population in
Transkei who are at the highest risk for EC in
South Africa have the highest daily corn
intake and also consume home-grown corn
containing the highest levels of fumonisins.
Thus, the PDI can be a useful estimate of the
fumonisins intake of population groups such
as the rural population in Transkei, and
although it can be applied to individuals by
means of food-from-the-plate analyses, this is
not easy to do.
Biomarkers are more accurate as measures
of individual intakes, but unfortunately, bio-
markers for human fumonisin intakes are not
yet available. However, fumonisins disrupt
sphingolipid biosynthesis (40), and the result-
ing elevation in the sphinganine/sphingosine
(Sa/So) ratio in serum, plasma, or urine has
been used as a biomarker in animals, includ-
ing nonhuman primates (62,63). Moreover,
analytical techniques have been developed to
determine Sa/So levels in humans, and ratios
of 0.09–0.78 have been reported in serum
(64) and ratios of 0.04–0.60 in urine (65,66).
In a recent article by van der Westhuizen
et al. (67), Sa/So ratios were reported in the
plasma and urine of residents of Kentani dis-
trict in the area with a high incidence of EC
in Transkei (Table 10). Although the mean
values were similar to those reported in
human serum and urine above, the upper
ranges of the ratios in both plasma (2.97) and
urine (5.75) were much higher than those
previously reported. It remains to be deter-
mined whether: 
• The Sa/So ratio is sensitive enough as a
biomarker of human intake of fumonisins
at the levels of contamination examined
to date (Table 10).
• Variation in the ratio between individuals
and within an individual over time can be
accommodated.
• Genetic polymorphisms of ceramide syn-
thase exist and contribute to individual
susceptibility to fumonisins.
• Individuals with high Sa/So ratios in areas
in Transkei with a high incidence of EC
have high intakes of fumonisins and are at
high risk for EC.
Y2K—Much more work remains to be done
on the fumonisins in the Third Millennium!
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